Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/192742
Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Photodynamic therapy (PDT) uses a combination of molecular oxygen, light and a photosensitizer (PS) to generate singlet oxygen or reactive oxygen species (ROS), which can eradicate tumoral cells. All currently approved PSs for cancer treatment are molecular PSs. To date, no nanoparticlebased PSs are used clinically although it has widely been shown that nanotechnology may help to improve the properties of molecular PSs; for instance, molecular PSs suffer from some intrinsic limitations that undermine their therapeutic efficacy. In the present minireview, the most critical weaknesses exhibited by molecular PSs are described, and the potential use of nanoparticles (NPs) to address them and to reach the clinics is discussed.
Subject
Subject (English)
Citation
Citation
SPINELLI, Guglielmo, CABALLERO HERNÁNDEZ, Ana Belén and GÁMEZ ENAMORADO, Patrick. Nanotechnological approaches to address photosensitizers' limitations: towards improved clinical applicability of photodynamic therapy. Chemistry Squared. 2022. Vol. 6, num. 2. ISSN 2604-0794. [consulted: 17 of August of 2026]. Available at: https://hdl.handle.net/2445/192742